ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 126 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $139,000 | +189.6% | 95,400 | +183.1% | 0.01% | +116.7% |
| Q4 2016 | $48,000 | +4.3% | 33,700 | +27.2% | 0.01% | +20.0% |
| Q3 2016 | $46,000 | -41.8% | 26,500 | -42.8% | 0.01% | -54.5% |
| Q2 2016 | $79,000 | +154.8% | 46,300 | +196.8% | 0.01% | +175.0% |
| Q1 2016 | $31,000 | -55.7% | 15,600 | -57.6% | 0.00% | -63.6% |
| Q4 2015 | $70,000 | -11.4% | 36,800 | +62.1% | 0.01% | -8.3% |
| Q4 2014 | $79,000 | – | 22,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
| DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
| Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
| Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
| Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
| OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
| FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
| HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |